¼¼°èÀÇ Ã·´Ü Á¤Çü¿Ü°ú ±â¼ú ½ÃÀå
Advanced Orthopedic Technologies
»óǰÄÚµå : 1737484
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 377 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,015,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,045,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

÷´Ü Á¤Çü¿Ü°ú ±â¼ú ¼¼°è ½ÃÀåÀº 2030³â±îÁö 731¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 590¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÷´Ü Á¤Çü¿Ü°ú ±â¼ú ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 3.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 731¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÀÓÇöõÆ®´Â CAGR 4.5%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 486¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àç»ý Á¦Ç° ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 2.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 161¾ï ´Þ·¯, Áß±¹Àº CAGR 6.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Ã·´Ü Á¤Çü¿Ü°ú ±â¼ú ½ÃÀåÀº 2024³â¿¡ 161¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 148¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¾î ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 6.9%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 1.4%¿Í 2.8%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.1%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ÷´Ü Á¤Çü¿Ü°ú ±â¼ú ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

÷´Ü Á¤Çü¿Ü°ú ±â¼úÀÌ ¿îµ¿¼±¼ö Ä¡·á¸¦ º¯È­½ÃŰ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

÷´Ü Á¤Çü¿Ü°ú ±â¼úÀº ¿îµ¿ÁúȯÀÇ Áø´Ü, Ä¡·á, ÀçȰ¿¡ Çõ¸íÀ» °¡Á®¿Ã ´Ù¾çÇÑ Çõ½Å ±â¼úÀ» Æ÷°ýÇϰí ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â Â÷¼¼´ë °üÀý ÀÓÇöõÆ®, ·Îº¿ º¸Á¶ ¼ö¼ú ½Ã½ºÅÛ, 3D ÇÁ¸°ÆÃ Á¤Çü¿Ü°ú Àåºñ, Á¤Çü¿Ü°ú ³»ºñ°ÔÀÌ¼Ç ¹× ¿µ»ó µµ±¸, »ý¹°ÇÐÀû Á¦Á¦ ¹× Àç»ý Ä¡·á, ½Ç½Ã°£ µ¥ÀÌÅÍ Çǵå¹éÀÌ °¡´ÉÇÑ ½º¸¶Æ® ÀÓÇöõÆ® µîÀÌ Æ÷ÇԵ˴ϴÙ. Àα¸ °í·ÉÈ­, Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏ, ºñ¸¸À² Áõ°¡·Î ÀÎÇØ °ñ°üÀý¿°, °ñÀý, ôÃß Áúȯ, ½ºÆ÷Ã÷ ¿Ü»ó µî Á¤Çü¿Ü°ú ÁúȯÀÇ ¹ß»ý·üÀÌ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó Á¤¹ÐÇϰí ÃÖ¼Ò Ä§½ÀÀûÀ̸ç Ä¡·á °á°ú¿¡ ÃÖÀûÈ­µÈ ÁßÀç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀüÅëÀûÀÎ ¼ö¼ú¹ý¿¡¼­ ±â¼ú ±â¹Ý Á¤Çü¿Ü°ú·ÎÀÇ ÀüȯÀº ÀÓ»óÀû Á¤È®µµ Çâ»ó, ¼ö¼ú ÈÄ ÇÕº´Áõ °¨¼Ò, ÀÔ¿ø ±â°£ ´ÜÃà, ȸº¹ ÀÏÁ¤ ´ÜÃà µîÀÇ Çʿ伺¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ·Îº¿ º¸Á¶ ¼ö¼úÀº ¿Ü°ú Àǻ簡 ¹Ð¸®¹ÌÅÍ ÀÌÇÏÀÇ Á¤È®µµ·Î ¼ö¼úÀ» ÇÒ ¼ö ÀÖ°Ô ÇÏ¿© ÀÓÇöõÆ® Á¤·ÄÀ» °³¼±Çϰí Àç¼ö¼ú·üÀ» ³·Ãâ ¼ö ÀÖ½À´Ï´Ù. ÇÑÆí, AI¸¦ Ȱ¿ëÇÑ ¿µ»ó ó¸® ¹× ¼ö¼ú Àü °èȹ µµ±¸´Â º¸´Ù °³ÀÎÈ­µÈ Ä¡·á Á¢±Ù¹ýÀ» °¡´ÉÇÏ°Ô Çϰí, 3D ÇÁ¸°ÆÃÀº ȯÀÚº° ÀÓÇöõÆ® ¹× ¼ö¼ú °¡À̵带 Á¦ÀÛÇÒ ¼ö ÀÖ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î Á¤Çü¿Ü°ú ÀÇ·á´Â ¼öµ¿ÀûÀÎ ¼ö¼ú¿¡¼­ ´Éµ¿ÀûÀÌ°í µ¥ÀÌÅÍ¿¡ ±â¹ÝÇÑ À̵¿¼º°ú »îÀÇ Áú ȸº¹À¸·Î ÀçÁ¤Àǵǰí ÀÖ½À´Ï´Ù.

±â¼ú Ç÷§Æû°ú Àç·áÀÇ Çõ½ÅÀº Á¤Çü¿Ü°ú Ä¡·áÀÇ ¹üÀ§¿Í ÁúÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

Á¤Çü¿Ü°ú ºÐ¾ß¿¡¼­´Â ¼ö¼úÀû Ä¡·á¿Í ºñ¼ö¼úÀû Ä¡·á °æ·Î¿¡ °ÉÃÄ ±Þ¼ÓÇÑ ±â¼ú ÅëÇÕÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ·Îº¿ ¹× ÄÄÇ»ÅÍ Áö¿ø ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀº ÇöÀç Àΰø°üÀý ġȯ¼ú°ú ôÃß ¼ö¼ú¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, ¼ö¼ú Áß ½Ç½Ã°£ Çǵå¹éÀ» Á¦°øÇϰí ÀÓÇöõÆ® »ðÀÔÀÇ ÆíÂ÷¸¦ ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ¶ÇÇÑ ¿¬ºÎÁ¶Á÷ÀÇ ±ÕÇü°ú ÀÎ´ë º¸Á¸À» Áö¿øÇÏ¿© ±â´ÉÀû °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² Áõ°­Çö½Ç(AR) ¹× °¡»óÇö½Ç(VR) µµ±¸°¡ Á¤Çü¿Ü°ú ±³À° ¹× ¼ö¼ú ½Ã¹Ä·¹À̼ǿ¡ µµÀÔµÇ¾î ¿Ü°úÀÇ»çÀÇ Áغñ¿Í ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

Àç·á°úÇÐÀº ƯÈ÷ Â÷¼¼´ë Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® °³¹ß¿¡ ÀÖ¾î Çõ½ÅÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ´Ù°ø¼º Ç¥¸é ±¸Á¶¸¦ °¡Áø ƼŸ´½°ú ÄÚ¹ßÆ®-Å©·Ò ÇÕ±ÝÀº °ñÀ¯ÂøÀ» °³¼±Çϰí, »ýü Èí¼ö¼º Æú¸®¸Ó¿Í ¼¼¶ó¹ÍÀº ¿Ü»ó °íÁ¤ ¹× ½ºÆ÷Ã÷ ÀÇÇп¡ ´ëÇÑ Àû¿ëÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ¼¾¼­°¡ ³»ÀåµÈ ½º¸¶Æ® ÀÓÇöõÆ®´Â »ýü ¿ªÇÐÀû ºÎÇÏ, Ä¡À¯ ÁøÇà »óȲ, °¨¿°ÀÇ Ãʱâ ¡Èĸ¦ ¸ð´ÏÅ͸µÇϱâ À§ÇØ È°¹ßÈ÷ °³¹ßµÇ°í ÀÖÀ¸¸ç, ¼ö¼ú ÈÄ ÀÓ»óÀÇ¿¡°Ô ½Ç¿ëÀûÀÎ µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, °ñÇü¼º´Ü¹éÁú(BMP), Áٱ⼼Æ÷ Ä¡·á, ´ÙÇ÷¼ÒÆÇ Ç÷Àå(PRP) µîÀÇ Àç»ý»ý¹°ÇÐÀû Á¦Á¦´Â ±â°èÀû ÁßÀ縸À¸·Î ÃæºÐÇÏÁö ¾ÊÀº °æ¿ì Á¶Á÷ º¹±¸¿Í ±â´É ȸº¹À» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.

¾î¶² ÀÓ»óÀû ¾Ð·Â, ȯÀÚÀÇ ±â´ë, ÀÇ·á ¿ªÇÐÀÌ ½ÃÀå ¼ö¿ä¸¦ Çü¼ºÇϰí Àִ°¡?

ÅðÇ༺ °üÀý Áúȯ, ¿Ü»ó °ü·Ã ¼Õ»ó, ¼±Ãµ¼º ±âÇü µî Áõ°¡·Î ÀÎÇØ °í¼º´É Á¤Çü¿Ü°ú ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ °í°üÀý ¹× ½½°üÀý ġȯ¼úÀ» ¹Þ´Â ÀþÀº ȯÀÚµéÀº Ȱµ¿ÀûÀÎ »ýȰ·Î µ¹¾Æ°¡°íÀÚ ÇÏ´Â ¿å±¸¸¦ °¡Áö°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÀÇ·áÁø°ú ¿Ü°úÀÇ»çµéÀº ¼ö¼úÀÇ Àϰü¼ºÀ» ³ôÀ̰í, ¼ö¼ú Áß À§ÇèÀ» ÁÙÀ̸ç, Áõ°Å¿¡ ±â¹ÝÇÑ ¼ö¼ú ÈÄ ÀçȰÀ» Áö¿øÇÏ´Â ±â¼úÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, º´¿ø°ú ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)´Â ÀÔ¿ø ºñ¿ë°ú ¼ö¼ú ÇÕº´ÁõÀ» ÁÙÀ̱â À§ÇØ ¿¹Ãø °¡´ÉÇÑ ÀÓ»óÀû, °æÁ¦Àû °¡Ä¡¸¦ Á¦°øÇϴ ÷´Ü Á¤Çü¿Ü°ú ½Ã½ºÅÛ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÁöºÒÀÚ¿Í ±ÔÁ¦ ±â°üÀº ¶ÇÇÑ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô Àå±âÀûÀÎ °üÀý ±â´É°ú ÀçÀÔ¿øÀ² °¨¼Ò¿¡ ±â¿©ÇÏ´Â ±â¼úÀ» ¿ì¼±½ÃÇϵµ·Ï ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô Àϰý ÁöºÒ ¸ðµ¨°ú °á°ú ±â¹Ý »óȯÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ·Îº¿ ½Ã½ºÅÛ°ú °­È­µÈ ȸº¹ ÇÁ·ÎÅäÄÝ¿¡ ÈûÀÔ¾î ¿Ü·¡ Àΰø°üÀý ġȯ¼úÀÇ °¡¿ë¼ºÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¤Çü¿Ü°ú ÀÇ·á´Â ´õ¿í È¿À²ÀûÀ̰í ȯÀÚ Áß½ÉÀûÀÎ ºÐ¾ß·Î º¯È­Çϰí ÀÖ½À´Ï´Ù.

Áö¿ª°ú Àü¹® ºÐ¾ß¸¦ ³Ñ¾î¼± ÷´Ü Á¤Çü¿Ü°ú ±â¼ú ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

÷´Ü Á¤Çü¿Ü°ú ±â¼ú ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº Àα¸ Åë°èÇÐÀû º¯È­, ÀÓ»ó Çõ½Å, ¼ö¼ú °Ç¼ö Áõ°¡, ÇコÄÉ¾î »ýŰè Àü¹Ý¿¡ °ÉÄ£ Àü·«Àû ÅõÀÚÀÔ´Ï´Ù. ºÏ¹Ì, ƯÈ÷ ¹Ì±¹¿¡¼­´Â °­·ÂÇÑ Á¤Çü¿Ü°ú ÀÎÇÁ¶ó, Á¶±â ±â¼ú µµÀÔ, À¯¸®ÇÑ »óȯ Á¦µµ ÇÁ·¹ÀÓ¿öÅ©°¡ ·Îº¿ ½Ã½ºÅÛ, ½º¸¶Æ® ÀÓÇöõÆ®, µðÁöÅÐ Ç÷¡´× Ç÷§ÆûÀÇ º¸±ÞÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ÀÇ·á±â±â ±â¾÷µéÀº AI, ³»ºñ°ÔÀ̼Ç, Àç»ý ¼Ö·ç¼Ç¿¡ ÃÊÁ¡À» ¸ÂÃá M&:A ¹× Á¦ÈÞ¸¦ ÅëÇØ Æ÷Æ®Æú¸®¿À¸¦ Áö¼ÓÀûÀ¸·Î È®ÀåÇϰí ÀÖ½À´Ï´Ù.

À¯·´¿¡¼­´Â °ø°ø ÀÇ·á ÅõÀÚ, °í·ÉÈ­, Àúħ½À Á¤Çü¿Ü°ú ¼¾ÅÍÀÇ º¸±ÞÀÌ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. µ¶ÀÏ, ÇÁ¶û½º, ¿µ±¹Àº ÷´Ü ÀÓÇöõÆ® ¹× ·Îº¿ º¸Á¶¸¦ Ȱ¿ëÇÑ Àΰø°üÀý ġȯ¼ú°ú ôÃß ¼ö¼úÀÇ ÁÖ¿ä ½ÃÀåÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Á¤Çü¿Ü°ú Áúȯ ºÎ´ã Áõ°¡, ¼±ÅÃÀû ¼ö¼ú¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë, º´¿ø ÀÚµ¿È­ ¹× ¼ö¼ú ·Îº¿¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇØ °¡Àå ºü¸¥ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Áß±¹, Àεµ, ÀϺ», Çѱ¹Àº Á¤Çü¿Ü°ú »ý»ê ´É·ÂÀ» ºü¸£°Ô È®ÀåÇϰí ÀÖÀ¸¸ç, ¿Ü°úÀÇ»ç ±³À° ¹× ±¹Á¦ ±â¼ú Á¦ÈÞ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®º°·Î´Â °üÀý Àç°Ç¼ú(°í°üÀý, ¹«¸­°üÀý, ¾î±ú°üÀý)ÀÌ ¿©ÀüÈ÷ °¡Àå Å« Ä«Å×°í¸®¸¦ Â÷ÁöÇϰí ÀÖÀ¸¸ç, ôÃß, ¿Ü»ó, ½ºÆ÷Ã÷ ÀÇÇÐÀº °íÁ¤¼ú, »ý¹°ÇÐÀû Á¦Á¦, ³»ºñ°ÔÀÌ¼Ç Áö¿øÀÇ ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ °í¼ºÀå ºÎ¹®À¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ½Ã½ºÅÛÀÌ ºÐ»êÇü ÀÇ·á ¹× °¡Ä¡ ±â¹Ý ÀÇ·á·Î ÀüȯµÊ¿¡ µû¶ó ¿Ü·¡ ȯÀÚ ¹× ¿Ü·¡ ȯ°æÀº ±â¼ú µµÀÔÀÇ Áß¿äÇÑ Ã¤³ÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ȯÀÚµéÀÇ ±â´ëÄ¡°¡ ÁøÈ­Çϰí ÀÇ·á ¼­ºñ½º Á¦°øÀÌ µðÁöÅÐÈ­µÊ¿¡ µû¶ó ÷´Ü Á¤Çü¿Ü°ú ±â¼ú ½ÃÀåÀº Á¤Çü¿Ü°ú ÀÇ·á¿¡¼­ À̵¿¼º ȸº¹, ±¸Á¶Àû ¿ÏÀü¼º, »îÀÇ ÁúÀ» ½ÇÇöÇÏ´Â ¹æ¹ýÀ» ÀçÁ¤ÀÇÇÔÀ¸·Î½á °ß°íÇϰí Àå±âÀûÀÎ ¼ºÀåÀ» ÀÌ·ê Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(ÀÓÇöõÆ®, Àç»ý Á¦Ç°);¿ëµµ(ôÃß ¿Ü°ú, µÎ°³¾Ç¾È¸é ¿Ü°ú, °üÀý ġȯ¼ú, ±âŸ ¿ëµµ);ÃÖÁ¾»ç¿ëÀÚ(º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 44°³»ç)

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ÀÎÀ§ÀûÀÎ ¼öÀÍ¿ø°¡ Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Global Industry Analysts´Â ¼¼°è ÁÖ¿ä ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®(1,4,949¸í), ½ÌÅ©ÅÊÅ©(62°³ ±â°ü), ¹«¿ª ¹× »ê¾÷ ´Üü(171°³ ±â°ü)ÀÇ Àü¹®°¡µéÀÇ ÀǰßÀ» ¸é¹ÐÈ÷ °ËÅäÇÏ¿© »ýŰ迡 ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ°í »õ·Î¿î ½ÃÀå Çö½Ç¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¸ðµç ÁÖ¿ä ±¹°¡ÀÇ Àü¹®°¡¿Í °æÁ¦ÇÐÀÚµéÀÌ °ü¼¼¿Í ±×°ÍÀÌ ÀÚ±¹¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀǰßÀ» ÃßÀû Á¶»çÇß½À´Ï´Ù.

Global Industry Analysts´Â ÀÌ·¯ÇÑ È¥¶õÀÌ ÇâÈÄ 2-3°³¿ù ³»¿¡ ¸¶¹«¸®µÇ°í »õ·Î¿î ¼¼°è Áú¼­°¡ º¸´Ù ¸íÈ®ÇÏ°Ô È®¸³µÉ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, Global Industry Analysts´Â ÀÌ·¯ÇÑ »óȲÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇϰí ÀÖ½À´Ï´Ù.

2025³â 4¿ù: Çù»ó ´Ü°è

À̹ø 4¿ù º¸°í¼­¿¡¼­´Â °ü¼¼°¡ ¼¼°è ½ÃÀå Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú Áö¿ªº° ½ÃÀå Á¶Á¤¿¡ ´ëÇØ ¼Ò°³ÇÕ´Ï´Ù. ´ç»çÀÇ ¿¹ÃøÀº °ú°Å µ¥ÀÌÅÍ¿Í ÁøÈ­ÇÏ´Â ½ÃÀå ¿µÇâ¿äÀÎÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.

2025³â 7¿ù: ÃÖÁ¾ °ü¼¼ Àç¼³Á¤

°í°´´Ôµé²²´Â °¢ ±¹°¡º° ÃÖÁ¾ ¸®¼ÂÀÌ ¹ßÇ¥µÈ ÈÄ 7¿ù¿¡ ¹«·á ¾÷µ¥ÀÌÆ® ¹öÀüÀ» Á¦°øÇØ µå¸³´Ï´Ù. ÃÖÁ¾ ¾÷µ¥ÀÌÆ® ¹öÀü¿¡´Â ¸íÈ®ÇÏ°Ô Á¤ÀÇµÈ °ü¼¼ ¿µÇ⠺м®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

»óÈ£ ¹× ¾çÀÚ °£ ¹«¿ª°ú °ü¼¼ÀÇ ¿µÇ⠺м® :

¹Ì±¹ÀÇ <>& Áß±¹ <>& ¸ß½ÃÄÚ <>& ij³ª´Ù <>&EU <>& ÀϺ» <>& Àεµ <>& ±âŸ 176°³±¹

¾÷°è ÃÖ°íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®: Global Industry AnalystsÀÇ Áö½Ä ±â¹ÝÀº ±¹°¡, ½ÌÅ©ÅÊÅ©, ¹«¿ª ¹× »ê¾÷ ´Üü, ´ë±â¾÷, ±×¸®°í ¼¼°è °è·® °æÁ¦ »óȲÀÇ Àü·Ê ¾ø´Â ÆÐ·¯´ÙÀÓ ÀüȯÀÇ ¿µÇâÀ» °øÀ¯ÇÏ´Â ºÐ¾ßº° Àü¹®°¡ µî °¡Àå ¿µÇâ·Â ÀÖ´Â ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ Æ÷ÇÔÇÑ 14,949¸íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ ÃßÀûÇϰí ÀÖ½À´Ï´Ù. 16,491°³ ÀÌ»óÀÇ º¸°í¼­ ´ëºÎºÐ¿¡ ¸¶ÀϽºÅæ¿¡ ±â¹ÝÇÑ 2´Ü°è Ãâ½Ã ÀÏÁ¤ÀÌ Àû¿ëµÇ¾î ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Advanced Orthopedic Technologies Market to Reach US$73.1 Billion by 2030

The global market for Advanced Orthopedic Technologies estimated at US$59.0 Billion in the year 2024, is expected to reach US$73.1 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Implants, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$48.6 Billion by the end of the analysis period. Growth in the Regenerative Products segment is estimated at 2.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$16.1 Billion While China is Forecast to Grow at 6.9% CAGR

The Advanced Orthopedic Technologies market in the U.S. is estimated at US$16.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$14.8 Billion by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Advanced Orthopedic Technologies Market - Key Trends & Drivers Summarized

Why Are Advanced Orthopedic Technologies Reshaping Musculoskeletal Care Across the Continuum?

Advanced orthopedic technologies encompass a wide array of innovations that are revolutionizing the diagnosis, treatment, and rehabilitation of musculoskeletal disorders. These include next-generation joint implants, robotic-assisted surgical systems, 3D-printed orthopedic devices, orthopedic navigation and imaging tools, biologics and regenerative therapies, and smart implantables with real-time data feedback. As the incidence of orthopedic conditions such as osteoarthritis, fractures, spinal disorders, and sports injuries continues to climb-driven by aging populations, active lifestyles, and higher rates of obesity-there is increasing demand for precision-based, minimally invasive, and outcome-optimized interventions.

The shift from conventional procedures to technology-enhanced orthopedics is being fueled by the need to improve clinical accuracy, reduce post-operative complications, shorten hospital stays, and accelerate recovery timelines. Robotic-assisted surgery, for example, enables surgeons to perform procedures with sub-millimeter precision, improving implant alignment and reducing revision rates. Meanwhile, AI-powered imaging and pre-operative planning tools are enabling more personalized treatment approaches, while 3D printing is allowing for the creation of patient-specific implants and surgical guides. These advancements are redefining orthopedic care from reactive surgery to proactive, data-driven restoration of mobility and quality of life.

How Are Technology Platforms and Material Innovations Elevating the Scope and Quality of Orthopedic Interventions?

The orthopedic sector is witnessing rapid technological integration across surgical and non-surgical treatment pathways. Robotic and computer-assisted navigation systems are now widely used in joint replacement and spine surgeries, allowing real-time intraoperative feedback and minimizing variability in implant placement. These systems also support soft tissue balancing and ligament preservation, leading to improved functional outcomes. In parallel, augmented reality (AR) and virtual reality (VR) tools are being introduced in orthopedic training and procedure simulation, enhancing surgeon preparedness and patient safety.

Material science is playing a transformative role, particularly in the development of next-gen orthopedic implants. Titanium and cobalt-chromium alloys with porous surface structures are improving osseointegration, while bioresorbable polymers and ceramics are expanding applications in trauma fixation and sports medicine. Smart implants embedded with sensors are under active development to monitor biomechanical loads, healing progress, and early signs of infection-providing clinicians with actionable data post-surgery. Furthermore, regenerative biologics such as bone morphogenetic proteins (BMPs), stem cell therapies, and platelet-rich plasma (PRP) are enabling tissue repair and functional recovery in cases where mechanical interventions alone are insufficient.

What Clinical Pressures, Patient Expectations, and Healthcare Dynamics Are Shaping Market Demand?

The rising burden of degenerative joint disease, trauma-related injuries, and congenital deformities is creating sustained demand for high-performance orthopedic technologies. Patients are increasingly expecting faster recovery, minimally invasive procedures, and long-lasting outcomes-especially younger patients undergoing hip or knee replacements who expect to return to active lifestyles. This has prompted healthcare providers and surgeons to adopt technologies that enhance procedural consistency, reduce intraoperative risks, and support evidence-based post-operative rehabilitation.

Additionally, the need to reduce hospitalization costs and surgical complications is leading hospitals and ambulatory surgery centers (ASCs) to invest in advanced orthopedic systems that offer predictable clinical and economic value. Payers and regulatory bodies are also promoting bundled payment models and outcome-based reimbursement, encouraging healthcare providers to prioritize technologies that contribute to long-term joint function and reduced readmission rates. The increased availability of outpatient joint replacement surgeries, supported by robotic systems and enhanced recovery protocols, is further transforming orthopedic care into a more efficient, patient-centric discipline.

What Is Driving the Growth of the Advanced Orthopedic Technologies Market Across Geographies and Subspecialties?

The growth in the advanced orthopedic technologies market is driven by demographic shifts, clinical innovation, rising surgical volumes, and strategic investments across healthcare ecosystems. In North America, particularly the U.S., strong orthopedic infrastructure, early technology adoption, and favorable reimbursement frameworks are supporting widespread use of robotic systems, smart implants, and digital planning platforms. Leading medical device companies continue to expand their portfolios through M&A and partnerships focused on AI, navigation, and regenerative solutions.

In Europe, market expansion is supported by public healthcare investments, aging populations, and the proliferation of minimally invasive orthopedic centers. Germany, France, and the UK are key markets for joint replacements and spine procedures leveraging advanced implants and robotic assistance. Asia-Pacific is witnessing the fastest growth, driven by rising orthopedic disease burden, expanding access to elective surgery, and increasing investment in hospital automation and surgical robotics. China, India, Japan, and South Korea are rapidly scaling their orthopedic capacity and investing in surgeon training and international technology partnerships.

Segment-wise, joint reconstruction (hip, knee, shoulder) remains the largest category, while spine, trauma, and sports medicine are emerging as high-growth segments due to innovations in fixation, biologics, and navigational support. Outpatient and ambulatory settings are becoming key channels for technology deployment as healthcare systems transition toward decentralized and value-based care. As patient expectations evolve and healthcare delivery becomes more digitally integrated, the global market for advanced orthopedic technologies is poised for robust, long-term growth-redefining how mobility restoration, structural integrity, and quality of life are achieved in orthopedic medicine.

SCOPE OF STUDY:

The report analyzes the Advanced Orthopedic Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Implants, Regenerative Products); Application (Spine Surgery, Cranial & Maxillofacial Surgery, Joint Replacement Surgery, Other Applications); End-User (Hospitals, Ambulatory Surgery Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â